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It is reputed that periodontal indices remain unchanged over a 24-hour period, with great clinical significance. This preliminary
study analyzes daily index changes. In 56 selected patients, full-mouth plaque score (FMPS), full-mouth bleeding score (FMBS),
periodontal screening and recording (PSR) indices, and periodontal risk assessment (PRA) were recorded at baseline and three
times per day (check-I: 08.30, check-II: 11.30, and check-III: 14.30), after appropriate cause-related therapy. Correlation between
variables was statistically analyzed by Stata. All periodontal indices improved at the examination phase. Statistical differences were
detected for FMPS comparing all thrice daily checks. Statistical differences were detected for FMBS and PRA comparing check-III
with check-I and check-II. PSR showed no significant changes. The worst baseline indices produced the widest daily fluctuation at
the examination phase. Significant variation of indices is directly related to clinical severity of periodontal conditions at baseline.
Patients affected by severe periodontal disease may show significantly greater index changes. As indices are routinely recorded
only once per day, the index daily variation has clinical significance. This greatly affects therapeutic strategy as correct periodontal
assessment requires multiple evaluations at standardized times, particularly when baseline conditions are severe.
1. Introduction
Maintenance of integrity and of biological rehabilitation,
function, and aesthetics are principal objectives in gen-
eral dentistry and periodontology [1, 2]. Dental health can
be jeopardized to varying degrees by different periodon-
tal diseases [3–7]. Periodontal diseases are oral disorders,
characterized by gingival and periodontal inflammation,
attachment loss, and alveolar bone resorption [4, 6, 7].
Oral microbiota, immune and inflammatorymediation, gene
regulation, and hormonal changes play important roles in
the onset of periodontal disease [8–10]. However, several
additional causes, sometimes linked to systemic diseases, but
also linked to psychological aspects or lifestyle, play roles
in the progression of periodontal damage. Wide evidence
exists in that daily stressors and stress vulnerability factors
are associated with inflammatorymarkers and endocrine and
immune functioning [5, 10, 11]. Moreover, it is known, thanks
to pioneering work on animals, that response to various
pathogens and their by-products including bacterial endo-
toxins and exotoxins and proinflammatory cytokines is under
diurnal control [12–19].Thaiss et al. [19] report that intestinal
microbiota undergoes diurnal oscillation, controlled by host
feeding time. Moreover, short-term rhythmic oscillations
in intestinal microbiota may be exaggerated or disrupted
under various disease conditions, impacting progression of
microbiota-mediated diseases with different manifestations
or with varying degrees of severity at different times of day
[19–21].Themucosal immune system found inside themouth
is similar to that of the small intestine [22, 23]. Dendritic
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cells, lymphocytes, and mucosal-associated lymphoid tissue
(in the tonsils and lymphoid follicles) help to sample contents
entering the mouth and determine “friend or foe.” Resident
bacteria in the oral cavity are critical to this process. However,
outside of dental circles, little attention has been paid to this
fact until now [24] or to the 45% overlap of microbes found
both in the mouth and in the colon [25]. Sato et al. [26], after
studying the oral bacteriome, observed that some bacterial
species exhibit significant changes in abundance over time
while the majority of species exhibited no periodic changes
over the course of a day. However, inter- and intraindividual
variability and stability of the human microbiome remain
poorly characterized, particularly at the intraday level [26].
Moreover, prevalence of periodontitis in several countries
is based upon indices of periodontal treatment screening [27–
29]. Consequently, clinical periodontal indices assume par-
ticular epidemiological, diagnostic, and prognostic impor-
tance in risk assessment and identification of appropriate
therapeutic strategy, given the lack of reliable pathogenic
criteria based specifically upon interpretation of type of
inflammation [4, 5, 30, 31]. Probing depth and clinical
attachment levels are used in the diagnosis or prognosis of
specific periodontal diseases, but these indicators are liable
tomisinterpretation, evenwhen correctlymeasured and even
when abundant microbiota deposition or gingivitis is present
[32–34]. These situations are frequent mainly during early
stages of periodontal therapy. Conservative, orthodontic,
and prosthetic issues, individual sensitivity to risk factors,
lifestyle, and pathological state requiring treatment, moti-
vate patients and achieve as standardized a periodontal
condition as possible. Cause-related periodontal therapy is
always performed during the oral hygiene education phase
to fulfill this purpose. The cause-related treatment reduces
periodontal inflammation and contributes to greater patient
status standardization [35].
The community periodontal index of treatment needs
(CPITN) and the periodontal screening and recording (PSR)
score are indices recommended by both the AmericanDental
Association and theAmericanAcademy of Periodontology as
screening tools to facilitate early detection and periodontal
disease treatment requirements [6, 36]. These indices are
not, however, a substitute for periodontal charting during
clinical and therapeutic periodontal evaluation but have great
importance during the initial stages of patient evaluation.
The full-mouth plaque score (FMPS) evidences presence of
microbiota [37] while full-mouth bleeding score (FMBS) [38]
evidences periodontal inflammation.
Periodontal risk assessment (PRA) consists in a func-
tional diagram that helps the clinician to determine the
risk of disease progression in individual patients [39] and is
particularly effective in compliant subjects not suffering from
aggressive periodontal disease [32, 40].
Treatment needs andmanagement of periodontal disease
depend largely upon accurate and reliable index recording,
development of an appropriate treatment plan, and sub-
sequent monitoring. However, since pioneering work by
Hoover and Lefkowitz [41], gingival inflammation has been
considered as a fluctuating disease with a daily cycle of
change.
At present, periodontal indices are routinely recorded
presupposing that they should not vary significantly, irrespec-
tive of the time of day. The aim of this study is to evaluate
periodontal FMBS, FMPS, PSR, and PRA indices intraday
changes during supportive periodontal therapy.
2. Materials and Methods
2.1. Study Population. The present study population was
selected from a list of systemically healthy subjects referred
for periodontal treatment, examined, and treated with cause-
related therapy.
Checks or improvement studies in health care without
external funding, performed by a clinician group working
in a single sanitary structure, require no ethical committee
approval according to Italian law (standard operating proce-
dure of the provincial ethical committee of Modena, revision
November 16, 2010).
All patients signed informed consent in which all proce-
dures of the study were detailed.The research was conducted
in full accordance with ethical principles, including the 2013
WMA Helsinki Declaration [42].
Subjects meeting the criteria reported in Table 1 were
enrolled.
Enrolled subjects were affected by onlymild periodontitis
[43, 44] and had not undergone periodontal treatment during
the previous year. Additionally, after completion of cause-
related therapy, subjects had to be considered good compliers
[1, 45, 46].
Each patient in this study had tomeet all the above criteria
in every phase of the clinical trial.
2.2. Study Design. Before patient examination and treatment,
a pretrial calibration session was performed by two exam-
iners on 10 healthy volunteer patients. Number of teeth
present in the oral cavity (NoT), FMPS, FMBS, and PSR
were recorded three times a day to obtain acceptable intra-
and interexaminer clinical periodontal parameter assessment
reproducibility.
The first step was the patient screening phase, anam-
nesis, preliminary dental visit, motivation, and preliminary
treatment after patient consent. Gingival tissue sanitization
was necessary to achieve a predictive periodontal diagnosis
particularly in patients lacking dental supportive therapy or
even with no history of regular dental examination for an
extended period of time. This step concerned initial dental
hygiene treatment and acute and urgent surgical, endodontic,
and conservative conditions requiring a short-term solution
to stabilize periodontal tissues.
The study opening visit was performed after completion
of the first step of causal therapy. The opening visit (baseline,
b) was carried out with a flat rhodium-plated dental mirror,
dental probe, and periodontal probe with 1-millimeter marks
(modified Click-Probe, Kerr Corp., Bioggio, Switzerland).
Full-mouth plaque score at baseline (FMPS-b), by plaque
disclosing gel detection, and full-mouth bleeding score at
baseline (FMBS-b) were assessed at six sites per tooth.
Periodontal screening and recording at baseline (PSR-b)
was assessed using the World Health Organization (WHO)
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Table 1: Systemic and specific inclusion criteria.
Systemic criteria
Absence of relevant medical conditions (subjects with a clear medical history and no physical or
psychological condition, psychotic disorders, personality disorders, which could affect their conduct in
the study).
Smoking status: nonsmokers or smokers up to 20 cigarettes a day (cigar or pipe smokers or people with a
story of alcohol and drug abuse were excluded).
Education: only patients having almost completed at least compulsory education.
Pregnant, lactating, and underage patients were excluded.
Local criteria
Subjects having more than 16 teeth, not wearing removable partial dentures, not showing oral
parafunctions, and not presenting severe skeletal and occlusal abnormalities or substantial oral
dysmorphism were enrolled.
Oral and periodontal conditions: absence of premalignant lesion of the oral cavity.
Treatment history: subjects who received scaling root planning, or periodontal surgical treatment in the
preceding 6 months, or undergoing recent orthodontic or prosthetic therapy were excluded.
Level of infection: subjects presenting with severe cariogenicity, stomatitis, acute abscesses, or gingival
fistulae were excluded.
periodontal probe. PSR was measured for each tooth and
sextant, but only the peak index value for each patient was
considered. Finally, PRA-b was calculated.
The following variables were routinely recorded:
(i) age;
(ii) gender;
(iii) body mass index (BMI) as previously described [7];
(iv) number of teeth (NoT) present in the oral cavity;
(v) glycemia (Gly).
Smoking habits (number of cigarettes per day [NoC];
current smoker, nicotinism; former smoker or nonsmoker,
and, if smoker, the number of years as smoker) were recorded.
Required cause-related therapy, including scaling and root
planning, was completed and oral hygiene instructions were
given. Indices at baseline were only considered in patients
who were subsequently enrolled in the study.
2.3. Study Outcomes and Data Analysis. Five weeks after
completion of the previous periodontal therapy, all patients
were reevaluated. Patients fulfilling the study inclusion crite-
ria and needing periodontal supportive therapywere enrolled
and a new examination (examination phase) was performed
the next week.
Each subject would be present at 3 different times (in a
single day) at the periodontal examination and maintained
usual daily routines. Checks (examination phase)were sched-
uled (check-I: 08.30, check-II: 11.30, and check-III: 14.30).
FMPS, FMBS, PSR, and PRA were considered during
each check. NoT was considered once during examination
phase. These data were compared with recorded clinical
indices, gender, and smoking habits.
2.4. Statistical Analyses. Inter- and intrarate comparisons
were carried out using Spearman coefficients for the number
of teeth, PSR, FMBS, FMPS, and PRA.
Comparisons between initial and check-I, check-II, and
check-III values for the considered variables were carried
out using the Wilcoxon signed-rank statistic (matched data),
while, for binary variables gender and smoking habit, com-
parisons between two independent groups (unmatched data)
were carried out using the Mann–Whitney test. Spearman
correlation coefficients between variables were calculated and
the null hypotheses that no relationship exists between the
pairs of variables were tested against the alternative (two-
tailed) hypotheses that a relationship exists. FMPS, FMBS,
PSR, and PRA were identified as dependent variables. The
relationship between dependent and independent (covari-
ates) variables was examined using the seemingly unrelated
regression (SUR) model. SUR was used to analyze the effects
of covariates on the level of the dependent variables on their
maximum observed between the check at the examination
phase equal to I, II, and III (that is, Δ-check, the maximum
gap between check-I, check-II, and check-III). The level of
significance of the applied tests was the standard value 𝛼 =
0.05.
Multivariate analysis of covariance (MANCOVA) for
repeated measurement was carried out for examination
phases in order to profile index changes over time and to
compare SUR results.
Statistical analysis was performed using Stata, version
14.00 (StataCorp LP, Lakeway Drive, College Station, TX,
USA) [47].
3. Results
Spearman test analysis of the calibration session, performed
by the two examiners on 10 healthy volunteer patients and
concerningNoT, FMPS, FMBS, and PSR, produced intrarater
agreement ranging between 0.782 and 1.000 (𝑝 < 0.001) and
interrater agreement ranging between 0.771 and 1.000 (𝑝 <
0.001).
Sixty-seven patients met all requirements of the exper-
imental protocol and study design. However, a total of 11
patients were excluded: 3 patients did not present at main-
tenance therapy visits conflicting with the study’s stringent
inclusion criteria; 6 patients (two females and four males)
missed the examination phase; 1 patient moved to a distant
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Table 2: Assessed periodontal indices, grouped by gender and smoker status.
Baseline Check-I Check-II Check-III
FMPS
Nonsmokers 48.7 ± 13.4 19.8 ± 8.9 17.0 ± 6.7 16.3 ± 5.2
Female 49.7 ± 14.4 22.5 ± 9.3 17.5 ± 6.5 16.5 ± 4.3
Male 47.7 ± 12.7 17.3 ± 7.9 17.2 ± 7.0 16.1 ± 6.0
Smokers 34.7 ± 15.5 20.6 ± 9.0 18.3 ± 7.9 20.4 ± 7.8
Female 32.8 ± 15.5 18.3 ± 8.7 17.8 ± 9.0 22.3 ± 8.6
Male 36.7 ± 15.9 23.1 ± 9.1 18.9 ± 7.0 18.4 ± 6.7
Overall 42.9 ± 15.8 20.1 ± 8.9 17.7 ± 7.1 18.0 ± 6.6
FMBS
Nonsmokers 24.2 ± 11.1 9.9 ± 6.4 9.7 ± 6.2 8.9 ± 6.6
Female 25.3 ± 12.2 10.0 ± 5.6 10.2 ± 5.5 9.7 ± 6.7
Male 23.1 ± 10.2 9.9 ± 7.2 9.3 ± 7.0 8.2 ± 6.7
Smokers 18.5 ± 12.1 8.3 ± 5.5 7.0 ± 6.6 6.5 ± 4.9
Female 17.6 ± 12.7 7.7 ± 6.1 8.2 ± 8.4 7.6 ± 5.8
Male 19.4 ± 12.1 9.0 ± 5.1 5.7 ± 3.6 5.3 ± 3.5
Overall 21.8 ± 11.8 9.2 ± 6.0 8.6 ± 6.4 7.9 ± 6.0
PSR
Nonsmokers 1.63 ± 0.46 0.89 ± 0.26 0.89 ± 0.22 0.86 ± 0.23
Female 1.66 ± 0.49 0.99 ± 0.11 0.97 ± 0.13 0.94 ± 0.12
Male 1.61 ± 0.45 0.79 ± 0.31 0.81 ± 0.26 0.79 ± 0.29
Smokers 1.40 ± 0.46 0.96 ± 0.14 0.86 ± 0.22 0.92 ± 0.15
Female 1.30 ± 0.41 0.96 ± 0.15 0.92 ± 0.18 0.97 ± 0.14
Male 1.51 ± 0.51 0.95 ± 0.13 0.80 ± 0.25 0.86 ± 0.15
Overall 1.54 ± 0.47 0.91 ± 0.22 0.88 ± 0.21 0.89 ± 0.20
PRA
Nonsmokers 16.8 ± 13.9 10.4 ± 10.3 10.4 ± 10.2 9.7 ± 9.7
Female 19.3 ± 17.5 12.0 ± 13.1 12.2 ± 12.9 11.4 ± 11.8
Male 14.4 ± 9.5 8.9 ± 6.8 8.6 ± 6.5 8.1 ± 7.2
Smokers 31.2 ± 16.2 17.6 ± 6.4 15.9 ± 8.2 14.2 ± 5.2
Female 25.5 ± 12.1 16.4 ± 7.7 16.2 ± 10.0 14.8 ± 5.3
Male 37.4 ± 18.4 18.9 ± 4.8 15.5 ± 6.1 13.5 ± 5.2
Overall 22.7 ± 16.4 13.4 ± 9.5 12.6 ± 9.7 11.5 ± 8.4
Values are expressed as mean ± standard deviation. FMPS: full-mouth plaque score; FMBS: full-mouth bleeding score; PSR: periodontal screening and
recording; PRA: periodontal risk assessment.
city; and 1 patient became pregnant.Therefore, 28 females (16
nonsmokers and 12 smokers) and 28 males (17 nonsmokers
and 11 smokers), aged 19–91 years (mean ± SD, 43.2 ± 15.7),
formed the test population.
3.1. Indices at Baseline. Ranges in nonsmokers were NoT
10–31, FMPS-b 20–67.4%, FMBS-b 2.4–41.3%, PSR-b 1.0–2.5,
and PRA-b 2.6–68.4. Ranges in smokers were NoT 10–30,
FMPS-b 12.9–68.0%, FMBS-b 2.4–43.1%, PSR-b 0.83–2.0, and
PRA-b 8.7–68.4. The greater FMPS-b and the lower PRA-b
of nonsmokers were statistically significant in both genders
when compared with smokers (Table 2).
3.2. Indices at Examination Phase. At check-I, ranges in
nonsmokers were FMPS 6.5-38.5%, FMBS 0.7–25.0%, PSR
0.03–1.2, and PRA 2.6–46.7. At check-I, ranges in smokers
were FMPS 7.0–35.3%, FMBS 1.2-19.2%, PSR 0.7–1.2, and PRA
8.7–29.9 (Table 2).
At check-II, ranges in nonsmokers were FMPS 3.3–35.0%;
FMBS 0.5–25.0%; PSR 0.2-1.2; PRA 2.6–46.7. At check-II,
ranges in smokers were FMPS 5.0–28.9%; FMBS 1.2–25.6%;
PSR 0.8–1.2; PRA 7.8–34.6 (Table 2).
At check-III, ranges in nonsmokers were FMPS 3.3–
28.4%, FMBS 0.01–22.8%, PSR 0.01–1.17, and PRA2.60–43.30.
At check-III, ranges in smokers were FMPS 5.6–36.0%, FMBS
2.0–18.5%, PSR 0.67–1.17, and PRA 8.66–25.12 (Table 2).
3.3. Clinical Outcomes. In all patients, FMPS, FMBS, PSR,
and PRA (Table 2) highlighted statistically significant clinical
improvements from baseline to the examination phase. In
all patients, statistically significant differences were recorded
between check-I, check-II, and check-III. PSR was almost
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Table 3: Nonparametric analysis of dental indices.
Females Males Nonsmokers Smokers Overall
I II I II I II I II I II
FMPS
I — — — — — — — — — —
II −2.7 — n.s. — n.s. — n.s. — −2.7 —
III n.s. n.s. n.s. n.s. −2.5 n.s. n.s. n.s. −2.1 n.s.
FMBS
I — — — — — — — — — —
II n.s. — −2.7 — n.s. — n.s. — n.s. —
III n.s. n.s. −3.3 n.s. n.s. −2.5 −2.5 n.s. −3.0 −2.3
PSR
I — — — — — — — — — —
II n.s. — n.s. — n.s. — −2.2 — n.s. —
III n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
PRA
I — — — — — — — — — —
II n.s. — −2.2 — n.s. — −2.0 — n.s. —
III n.s. n.s. −3.4 −2.2 −2.0 −2.5 −3.0 n.s. −3.4 −2.4
Significant coefficients afterMann–Whitney test. FMPS: full-mouth plaque score; FMBS: full-mouth bleeding score; PSR: periodontal screening and recording;
PRA: periodontal risk assessment. I: check-I; II: check-II; III: check-III; n.s.: not significant.
Table 4: Significance of dental indices at examination phase after Spearman test.
PRA-III PSR-III FMBS-III FMPS-III PRA-II PSR-II FMBS-II FMPS-II PRA-I PSR-I FMBS-I
FMPS-I n.s. n.s. 0.4 0.4 n.s. 0.4 0.5 0.7 n.s. 0.7 0.6
FMBS-I 0.4 n.s. 0.8 n.s. 0.4 0.3 0.9 0.3 0.4 0.4
PSR-I n.s. 0.5 0.4 0.4 n.s. 0.6 0.3 n.s. n.s.
PRA-I 0.9 n.s. 0.3 0.3 0.9 n.s. 0.4 n.s.
FMPS-II n.s. 0.2 n.s. 0.5 n.s. 0.3 n.s.
FMBS-II 0.4 n.s. 0.9 n.s. 0.4 0.4
PSR-II n.s. 0.7 0.4 n.s. n.s.
PRA-II 0.9 n.s. 0.4 n.s.
FMPS-III 0.3 0.4 n.s.
FMBS-III 0.4 0.3
PSR-III n.s.
Significant coefficients after Spearman test. Only variables abutting almost one significant correlation are reported. FMPS: full-mouth plaque score; FMBS: full-
mouth bleeding score; PSR: periodontal screening and recording; PRA: periodontal risk assessment. I: check-I; II: check-II; III: check-III; n.s.: not significant.
not significant, whereas FMBS, FMPS, and PRA were often
significant (Table 3).
Check-I and check-II FMPS values were significantly
different in females, whereas check-I FMBS value was signif-
icantly different from check-II and check-III FMBS values in
males (Table 3). Check-I, check-II and check-III PSR values
were not statistically different in either females or males.
Check-II and check-III PSR values were significantly greater
in females than in males (Table 2). Check-I, check-II and
check-III PRA values were statistically different in males, but
not in females (Table 3).
Check-I FMPS value was significantly different from
check-III FMPS value in nonsmokers (Table 3). Check-
III FMBS values were significantly different from check-
II FMBS value in nonsmokers and check-I FMBS value in
smokers. Check-I PSR value was significantly different from
check-II PSR value in smokers. Check-III PRA value was
significantly different from check-I and check-II PRA values
in nonsmokers, whereas check-I PRA value was significantly
different from check-II and check-III PRA values in smokers
(Table 3).
Several significant positive correlations between dental
indices at examination phases (check-I, check-II, and check-
III) were found after the Spearman test was performed
(Table 4).
3.4. SUR Analysis. SUR multivariate analysis highlighted
several statistically significant relationships between dental,
individual, and lifestyle indices versus periodontal indices
(Table 5).
Older patients showed a significant decrease of 1.3 units
of FMPS-Δ and 0.5 units of FMBS-Δ relative to the expected
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Table 5: Baseline andmaximum gap between check-I, check-II, and check-III of indices after seemingly unrelated regression (SUR) analysis.
FMPS FMBS PSR PRA







FMPS-b — −0.07 0.02
(0.001) (0.001)
FMBS-b — 0.16 0.03 −0.01 0.7 0.08
(0.001) (0.001) (0.001) (0.001) (0.005)
PSR-b 28.2 5.45 14.3 — −9.1
(0.001) (0.002) (0.001) (0.005)
PRA-b 0.5 −0.01 0.01 —
(0.001) (0.001) (0.039)
Δ-NoT −7.0 −10.8 0.45 14.9
(0.007) (0.001) (0.001) (0.001)
Estimated coefficients and 𝑝 values (in brackets) for the 4 seemingly unrelated regressions. Only variables abutting almost one significant correlation are
reported. FMPS: full-mouth plaque score; FMBS: full-mouth bleeding score; PSR: periodontal screening and recording; PRA: periodontal risk assessment;
NoC: number of cigarettes (per day);Δ-NoT: number of hopeless teeth extracted during cause-related therapy. b: baseline;Δ:Δ-check (maximum gap between
check-I, check-II, and check-III).
indices of patients 10 years younger. Women showed a
significantly decreased PSR-Δ. An increase of 20 cigarettes
per day caused a significant PSR-Δ reduction of 0.4 units
(Table 5), whereas smokers (nicotinism) showed an increased
PRA-Δ of approximately 4 units.
The 20% increase in FMBS at baseline (FMBS-b) pro-
duced a significant increase of FMBS-Δ (Δ-check, the max-
imum gap between check-I, check-II, and check-III) of 3.2%,
PRA-Δ of 1.6 units, and a minimal decrease of PSR-Δ. The
2-unit increase of PSR-b produced a significant increase of
approximately 11% FMPS-Δ. The 20-unit increase of PRA-b
produced a significant increase of PSR-Δ of 0.2 units (Table 5).
SUR analysis of baseline values is reported in Table 5.
4. Discussion
Periodontal screening tests require probing to assess peri-
odontal attachment loss circumferential to each dental ele-
ment or dental implant. To assess the risk of disease progres-
sion, a useful tool can be found in PRA (periodontal risk
assessment), consisting of a functional diagram [39]. PSR is a
useful test for periodontal screening as it is sensitive, specific,
inexpensive, quick, and simple to perform, limiting the num-
ber of possible errors associated only with probing proce-
dures [28, 29, 31, 33]. This present study was performed
relating to the initial stages of periodontal examination and
supportive treatment. PSR is particularly useful during the
initial phase and is particularly important in order to deter-
mine periodontal treatment requirements [6, 36, 46]. FMBS
and FMPS are, respectively, indices of inflammation and of
microbiota presence and should be obtained early. Regarding
systemic predisposition to inflammatory disorders, several
risks and prognostic factors are probably challenges that
trigger or worsen periodontal disorders. Therefore, patients
affected by systemic and oral health conditions that could
potentially introduce disturbing variables were excluded [5,
48, 49]. Stringent enrollment criteria were applied and the
decision to perform the examination phase was made only
after and temporally close to a positive response to causal
therapy in order to achieve a reliable clinical outcome and
an excellent standard of oral clinical settings, thus avoiding
potentially perturbing variables.
Enrolled patients were affected by only mild periodon-
titis, but not by moderate or severe periodontitis [43, 44].
The nosology of periodontitis is complex and currently being
developed and studied. In this present study, patients affected
by advanced periodontitis were excluded. This decision was
made to reduce the impact of major confounding variables
resulting from the complexity of severe periodontitis which
exacerbates other risk conditions and frequently entails
elaborate and significantly different therapeutic strategies [2,
4, 43, 44, 50, 51].
Different forms of periodontal disease require different
therapeutic strategies. Furthermore, a specific periodontal
lesion may not always be treatable in the same manner, but
rather on a case-specific basis [52, 53]. Further research,
therefore, may suddenly present new therapeutic strategies
[54, 55]. Consequently, it may be more difficult to obtain
examiner agreement regarding patients with moderate or
severe periodontitis due to haste and/or inaccurate, immod-
erate assessment [56–59].
The use of specific dental indices, specific periodontal
probes, and a preventive calibration session make exam-
iner agreement more obtainable and reliable [56, 59, 60].
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Furthermore, patients progressing to the examination phase
of this present study were required not to change their
daily habits and were examined delicately three times in
one day. A large number of exogenous variables potentially
able to produce misleading results during the examination
phase were eliminated thus creating the necessary conditions
to obtain significantly similar measurements. Nevertheless,
baseline data recorded using the same accurate method used
during the three check phases were included in order to
detect possible influences on index fluctuation. The baseline
situation is a key factor in both therapeutic decisions and
clinical outcomes [51, 61].
Most studies report reproducibility of the same peri-
odontal indices while using different measuring instruments
[60, 62, 63], in different clinical situations [31, 33, 59, 60],
and evaluating clinical correlation or reproducibility of the
same indices [64]. However, only few studies report the daily
periodontal indices trend [65].
The results of this present study highlight the clinical
effectiveness of cause-related therapy in genders, smokers
and nonsmokers, and also additional correlations such as the
direct relationship of periodontal indices during the exami-
nation phase.
Themain aim of this present study is to analyze periodon-
tal indices to ascertain whether or not these indices remain
unchanged during the day during the examination phase. In
the examination phase, significant changes of FMPS, FMBS,
and PRA, but not of PSR, were recorded. Similar significant
variations were also observed in nonsmokers.The substantial
changes detected in some of the aforementioned periodontal
indices have no easy explanation. Periodontal risk assessment
variation during the examination phase is significant. How-
ever, statistical analysis of PRA changes over time (during the
examination phase) showed a statistically similar trend to not
only FMBS but also to both FMPS and PSR.
Multivariate analysis can help us to understand these
variations by showing that a rise in either PRA-b or PSR-
b increases PSR Δ-check (with cumulative effect) and that
a rise in either FMBS-b or NoC increases FMBS Δ-checks.
Separately, a rise in either PSR-b or female gender increases
FMPS Δ-checks, and a rise in either FMBS-b or nicotinism
increases PRA Δ-checks (with cumulative effect). Among
the considered variables, any one related to either lifestyle
or biologic condition of the subject appears to influence Δ-
check widths in a different manner. However, many of the
measured variables significantly associated with Δ-checks
are periodontal indices recorded at baseline and produce an
increase of Δ-check widths. Therefore, the worst periodontal
indices at baseline produce the widest daily fluctuation at
the examination phase, considering the cumulative effect of
overall influencing factors. It is probable that, at baseline,
subjects suffering from serious periodontal conditions show
greater periodontal state instability which is further increased
by presence of risk factors such as nicotinism. Nevertheless,
patients enrolled in this present study suffered fromonlymild
periodontitis in the worst case. Patients were compliant with
study prescriptions and observed the stringent supportive
protocol and, on the whole, showed clinically favorable
indices during the examination phase.
Biological processes displaying endogenous fluctuation
had been widely observed in animals and human beings.
It is probable that this fluctuation stimulates physiologi-
cal mechanisms that promote adjustment to environmental
circumstances, favoring systemic requirements [66, 67]. It
is hard to separate behavioral and physiological influences
on the daily index fluctuation, also considering the mutual
correlation between those factors. Different check times
during the day may characterize dissimilar situations due to
systemic physiology, habits, lifestyle, activities, hygiene, and
nutrition. It is known that the alimentary canal macrobiome
also shows short-term oscillations related to diet and lifestyle
[19–21] and that these oscillations also seem to occur in
the oral cavity. However, there are fewer studies and less
evidence regarding this [26]. Gingival flow rate and human
crevicular fluid flow vary during the day in relation to eating,
chewing, and other stimuli [68, 69], particularly in presence
of gingival inflammation and the tonicity of saliva increases
with saliva flow rate. Additionally, daily oscillations in the
expression of inflammatory, immunological, and promigra-
tory molecules have also been described in humans. Several
chronic disease symptoms or presentations are known to be
exacerbated by daily stressors and worrying which create a
stress vulnerability factor [11, 18]. Gene transcription also
seems to be time of day dependent in some cases [8]. Even
human fibroblasts could have substantial daily variations
[70]. Periodontal disease is substantially a set of inflammatory
disorders largely supported by microbiota but also supported
by other risk and prognostic factors.
The examination phase was performed during three
different time slots: early morning, late morning, and early
afternoon. These times of day seem to have a neurophysi-
ologic and hormonal meaning in both mammals [71] and
humans and are linked to circumstances and different habits
related to working rhythms, dietary habits, and lifestyle.
Very few studies comparing the same periodontal indices
during the day are found in the literature. In this present
study, repeated measurements at different times on the same
day were performed in compliant patients affected by mild
periodontitis. Repeatedmeasurements performed at different
times along several days would introduce greater behavioral
and/or physiological effects. This present study observed
fluctuations within the same indices on the same day. These
fluctuations were significant and significantly proportional
with respect to the clinical severity of periodontal damage at
baseline but not at examination phase. It is therefore conceiv-
able that these fluctuations are more important in patients
affected by severe or serious periodontal disease due to the
fact that the pathological substrate may still be active also
after stabilization of the clinical condition. It is also possible
that daily fluctuations of the oral microbiota, inflammatory
and immunological regulation, and even cellular constituents
of periodontal tissue amplify indices variation. However, this
present study demonstrates that the discrepancy between
index measurements seems to be directly related to clinical
severity of the periodontal condition at baseline.Therefore, it
is conceivable that in patients affected by severe periodontal
disease the recognizable variations could become dramatic
even if the single indexmeasurement is performed at a second
8 International Journal of Dentistry
phase after baseline when signs of periodontal damage are
much less evident. This could even misdirect the therapeutic
strategy due to the fact that the predictivemeasurement refer-
able to the patients’ therapeutic feasibility of recovery could
be unknown.
5. Conclusion
Our results showed significant variation within indices
directly related to clinical severity of the periodontal con-
dition at baseline. Patients affected by severe periodontal
disease may show much larger index changes. Since the indi-
ces are routinely recorded only once, the index daily variation
may have actual clinical significance.This could greatly affect
therapeutic strategy because correct periodontal assessment
requires multiple evaluations with standardized timing, par-
ticularly when the baseline condition is severe.
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